{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:23:46Z","timestamp":1791242626147,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL120507"],"award-info":[{"award-number":["HL120507"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CX001550BX001984"],"award-info":[{"award-number":["CX001550BX001984"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CX001550"],"award-info":[{"award-number":["CX001550"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL124266"],"award-info":[{"award-number":["R01 HL124266"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA177558"],"award-info":[{"award-number":["P30 CA177558"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM103527"],"award-info":[{"award-number":["GM103527"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015087","name":"Markey Cancer Center, University of Kentucky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007472","name":"University of Kentucky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007472","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.yjmcc.2020.09.011","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T02:54:47Z","timestamp":1601607287000},"page":"95-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction"],"prefix":"10.1016","volume":"149","author":[{"given":"Himi","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Darraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abo-Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elica","family":"Shokri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshman","family":"Chelvarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"R. Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryana M.","family":"Levitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abdel-Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.yjmcc.2020.09.011_bb0005","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1084\/jem.20070885","article-title":"The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions","volume":"204","author":"Nahrendorf","year":"2007","journal-title":"J. Exp. Med."},{"issue":"20","key":"10.1016\/j.yjmcc.2020.09.011_bb0010","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1161\/CIRCULATIONAHA.115.016160","article-title":"Targeting interleukin-1beta reduces leukocyte production after acute myocardial infarction","volume":"132","author":"Sager","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.011_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvq052","article-title":"Autotaxin--an LPA producing enzyme with diverse functions","volume":"148","author":"Nakanaga","year":"2010","journal-title":"J. Biochem."},{"issue":"9","key":"10.1016\/j.yjmcc.2020.09.011_bb0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbalip.2008.05.008","article-title":"Roles of lysophosphatidic acid in cardiovascular physiology and disease","volume":"1781","author":"Smyth","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yjmcc.2020.09.011_bb0025","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3389\/fphys.2018.01315","article-title":"Lysophosphatidic acid is associated with cardiac dysfunction and hypertrophy by suppressing autophagy via the LPA3\/AKT\/mTOR pathway","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.011_bb0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/ATVBAHA.112.300527","article-title":"Lipid phosphate phosphatase 3 negatively regulates smooth muscle cell phenotypic modulation to limit intimal hyperplasia","volume":"33","author":"Panchatcharam","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.09.011_bb0035","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/ATVBAHA.113.302335","article-title":"Mice with targeted inactivation of ppap2b in endothelial and hematopoietic cells display enhanced vascular inflammation and permeability","volume":"34","author":"Panchatcharam","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.09.011_bb0040","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cmet.2011.02.016","article-title":"Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium","volume":"13","author":"Zhou","year":"2011","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.09.011_bb0045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/ATVBAHA.113.302737","article-title":"Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis","volume":"34","author":"Smyth","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7\u20138","key":"10.1016\/j.yjmcc.2020.09.011_bb0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/00365510310003265","article-title":"Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction","volume":"63","author":"Chen","year":"2003","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.011_bb0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1387\/ijdb.082745de","article-title":"Generation of a reporter-null allele of Ppap2b\/Lpp3and its expression during embryogenesis","volume":"53","author":"Escalante-Alcalde","year":"2009","journal-title":"Int. J. Dev. Biol."},{"issue":"12","key":"10.1016\/j.yjmcc.2020.09.011_bb0060","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni.3296","article-title":"A map of the distribution of sphingosine 1-phosphate in the spleen","volume":"16","author":"Ramos-Perez","year":"2015","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.09.011_bb0065","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/ATVBAHA.119.312592","article-title":"Genetic deficiency of Flavin-containing monooxygenase 3 ( Fmo3) protects against thrombosis but has only a minor effect on plasma lipid levels-brief report","volume":"39","author":"Shih","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.yjmcc.2020.09.011_bb0070","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.110.223925","article-title":"A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse","volume":"107","author":"Gao","year":"2010","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.011_bb0075","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/jpet.110.165845","article-title":"A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation","volume":"334","author":"Gierse","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.yjmcc.2020.09.011_bb0080","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.5966\/sctm.2014-0273","article-title":"Pharmacological elevation of circulating bioactive Phosphosphingolipids enhances myocardial recovery after acute infarction","volume":"4","author":"Klyachkin","year":"2015","journal-title":"Stem Cells Transl. Med."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.09.011_bb0085","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1194\/jlr.M039685","article-title":"Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice","volume":"54","author":"Salous","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.yjmcc.2020.09.011_bb0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-1-61779-430-8_27","article-title":"A mouse model of diet-induced obesity and insulin resistance","volume":"821","author":"Wang","year":"2012","journal-title":"Method. Mol. Biol. (Clifton, N.J.)"},{"issue":"5","key":"10.1016\/j.yjmcc.2020.09.011_bb0095","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3892\/etm.2016.3132","article-title":"Effect of lysophosphatidic acid on the immune inflammatory response and the connexin 43 protein in myocardial infarction","volume":"11","author":"Zhang","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"8","key":"10.1016\/j.yjmcc.2020.09.011_bb0100","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.115.016757","article-title":"Autotaxin derived from lipoprotein(a) and valve interstitial cells promotes inflammation and mineralization of the aortic valve","volume":"132","author":"Bouchareb","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.yjmcc.2020.09.011_bb0105","first-page":"1056","article-title":"Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology","volume":"9","author":"Shantsila","year":"2011","journal-title":"JTH"},{"issue":"9","key":"10.1016\/j.yjmcc.2020.09.011_bb0110","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/eci.12118","article-title":"Targeting inflammatory pathways in myocardial infarction","volume":"43","author":"Christia","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.yjmcc.2020.09.011_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136629","article-title":"Type I interferons function as autocrine and paracrine factors to induce Autotaxin in response to TLR activation","volume":"10","author":"Song","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.yjmcc.2020.09.011_bb0120","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1164\/rccm.201306-1014OC","article-title":"Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation","volume":"188","author":"Park","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.09.011_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10030073","article-title":"Coming of age for Autotaxin and Lysophosphatidate signaling: clinical applications for preventing, detecting and targeting tumor-promoting inflammation","volume":"10","author":"Benesch","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"45","key":"10.1016\/j.yjmcc.2020.09.011_bb0130","doi-asserted-by":"crossref","first-page":"16029","DOI":"10.1073\/pnas.1406508111","article-title":"Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart","volume":"111","author":"Lavine","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.yjmcc.2020.09.011_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014429","article-title":"Myocarditis in CD8-depleted SIV-infected rhesus macaques after short-term dual therapy with nucleoside and nucleotide reverse transcriptase inhibitors","volume":"5","author":"Annamalai","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.yjmcc.2020.09.011_bb0140","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0735-1097(01)01721-1","article-title":"Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling","volume":"39","author":"Maekawa","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15","key":"10.1016\/j.yjmcc.2020.09.011_bb0145","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jacc.2009.08.089","article-title":"Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis","volume":"55","author":"Panizzi","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.09.011_bb0150","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/jcmm.14005","article-title":"Autotaxin\/lysophosphatidic acid signaling mediates obesity-related cardiomyopathy in mice and human subjects","volume":"23","author":"Weng","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.09.011_bb0155","first-page":"187","article-title":"Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype","volume":"38","author":"Horckmans","year":"2017","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.09.011_bb0160","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cmet.2014.03.029","article-title":"Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity","volume":"19","author":"Nagareddy","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.yjmcc.2020.09.011_bb0165","doi-asserted-by":"crossref","first-page":"40144","DOI":"10.1038\/srep40144","article-title":"Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment","volume":"7","author":"Gensel","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yjmcc.2020.09.011_bb0170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejphar.2019.02.001","article-title":"Inhibition of microRNA-155 attenuates sympathetic neural remodeling following myocardial infarction via reducing M1 macrophage polarization and inflammatory responses in mice","volume":"851","author":"Hu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.09.011_bb0175","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4049\/jimmunol.1801228","article-title":"Azithromycin polarizes macrophages to an M2 phenotype via inhibition of the STAT1 and NF-kappaB signaling pathways","volume":"203","author":"Haydar","year":"2019","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.09.011_bb0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nri3800","article-title":"Role of innate and adaptive immune mechanisms in cardiac injury and repair","volume":"15","author":"Epelman","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.09.011_bb0185","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/nm.3284","article-title":"B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction","volume":"19","author":"Zouggari","year":"2013","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.09.011_bb0190","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.yexcr.2015.03.016","article-title":"Lysophospholipid mediators in the vasculature","volume":"333","author":"Mueller","year":"2015","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.09.011_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005061","article-title":"Lipid-induced epigenomic changes in human macrophages identify a coronary artery disease-associated variant that regulates PPAP2B expression through altered C\/EBP-beta binding","volume":"11","author":"Reschen","year":"2015","journal-title":"PLoS Genet."},{"issue":"13","key":"10.1016\/j.yjmcc.2020.09.011_bb0200","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/CIRCULATIONAHA.119.043833","article-title":"Neutrophil-derived S100A8\/A9 amplify Granulopoiesis after myocardial infarction","volume":"141","author":"Sreejit","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.yjmcc.2020.09.011_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063718","article-title":"Lysophosphatidic acid mediates myeloid differentiation within the human bone marrow microenvironment","volume":"8","author":"Evseenko","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2020.09.011_bb0210","doi-asserted-by":"crossref","first-page":"11410","DOI":"10.1038\/srep11410","article-title":"The lysophosphatidic acid receptor LPA4 regulates hematopoiesis-supporting activity of bone marrow stromal cells","volume":"5","author":"Igarashi","year":"2015","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.yjmcc.2020.09.011_bb0215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cellimm.2014.04.010","article-title":"Lysophosphatidylcholine perpetuates macrophage polarization toward classically activated phenotype in inflammation","volume":"289","author":"Qin","year":"2014","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.011_bb0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng.2480","article-title":"Large-scale association analysis identifies new risk loci for coronary artery disease","volume":"45","author":"Deloukas","year":"2013","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.09.011_bb0225","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.09.011_bb0230","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0002-9343(74)90603-2","article-title":"Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm","volume":"56","author":"Bulkley","year":"1974","journal-title":"Am. J. Med."},{"issue":"20","key":"10.1016\/j.yjmcc.2020.09.011_bb0235","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1161\/CIRCULATIONAHA.110.004671","article-title":"Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study","volume":"123","author":"Schjerning Olsen","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.yjmcc.2020.09.011_bb0240","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ni.1976","article-title":"IL-1beta-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKbeta","volume":"12","author":"Hsu","year":"2011","journal-title":"Nat. Immunol."},{"issue":"9987","key":"10.1016\/j.yjmcc.2020.09.011_bb0245","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/S0140-6736(15)61153-9","article-title":"Anti-inflammatory therapies in myocardial infarction","volume":"385","author":"Abbate","year":"2015","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.yjmcc.2020.09.011_bb0250","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.yjmcc.2020.09.011_bb0255","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-2600(18)30181-4","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial","volume":"6","author":"Maher","year":"2018","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.09.011_bb0260","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yexcr.2014.11.020","article-title":"Lysophospholipid receptors in drug discovery","volume":"333","author":"Kihara","year":"2015","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.09.011_bb0265","doi-asserted-by":"crossref","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","article-title":"Guidelines for experimental models of myocardial ischemia and infarction","volume":"314","author":"Lindsey","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2020.09.011_bb0270","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41590-018-0272-2","article-title":"Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction","volume":"20","author":"Dick","year":"2019","journal-title":"Nat. Immunol."},{"issue":"22","key":"10.1016\/j.yjmcc.2020.09.011_bb0275","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.109.916346","article-title":"Monocytes: protagonists of infarct inflammation and repair after myocardial infarction","volume":"121","author":"Nahrendorf","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.yjmcc.2020.09.011_bb0280","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/1541-7786.MCR-09-0288","article-title":"Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration","volume":"8","author":"Ptaszynska","year":"2010","journal-title":"MCR"},{"issue":"7","key":"10.1016\/j.yjmcc.2020.09.011_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200474","article-title":"Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: potential therapeutic targets in ischemic heart disease","volume":"13","author":"Al-Darraji","year":"2018","journal-title":"PLoS One"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282820302911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282820302911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:29:38Z","timestamp":1778632178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282820302911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":57,"alternative-id":["S0022282820302911"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2020.09.011","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2020.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}